Medicines for Malaria Venture

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:nonprofit_organization
gptkbp:abbreviation	gptkb:MMV
gptkbp:CEO	gptkb:David_Reddy
gptkbp:collaboratesWith	gptkb:World_Health_Organization academic institutions governments non-governmental organizations pharmaceutical companies
gptkbp:country	gptkb:Switzerland
gptkbp:focus	global health malaria drug development
gptkbp:founded	1999
gptkbp:fundedBy	gptkb:Irish_Aid gptkb:United_States_Agency_for_International_Development gptkb:Bill_&_Melinda_Gates_Foundation gptkb:Wellcome_Trust gptkb:Australian_Government_Department_of_Foreign_Affairs_and_Trade gptkb:Swiss_Agency_for_Development_and_Cooperation gptkb:UK_Department_for_International_Development
gptkbp:headquarters_location	gptkb:Geneva
gptkbp:mission	reduce the burden of malaria through the discovery, development and delivery of new, effective and affordable antimalarial drugs
gptkbp:notableProject	gptkb:artemether-lumefantrine_(Coartem_Dispersible) gptkb:artesunate-amodiaquine_(ASAQ_Winthrop) gptkb:pyronaridine-artesunate_(Pyramax) gptkb:tafenoquine_(Kozenis)
gptkbp:organization	gptkb:public-private_partnership
gptkbp:status	active
gptkbp:website	https://www.mmv.org/
gptkbp:bfsParent	gptkb:Roll_Back_Malaria_Partnership
gptkbp:bfsLayer	6
https://www.w3.org/2000/01/rdf-schema#label	Medicines for Malaria Venture